Antiviral drug linked to SARS-CoV-2 mutations
Francis Crick Institute press release
Under strict embargo: 16:00hrs BST 25 September 2023
Peer reviewed
Observational study
People
Antiviral drug linked to SARS-CoV-2 mutations
Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town and UKHSA have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
Molnupiravir works by inducing mutations in the virus’s ...














